Orthopediatrics (KIDS) Common Equity (2015 - 2026)

Orthopediatrics' Common Equity history runs 12 years deep, the most recent figure standing at $338.7 million for Q1 2026.

• In Q1 2026, Common Equity fell 2.43% year-over-year to $338.7 million; the TTM figure through Mar 2026 stood at $338.7 million (down 2.43% YoY), while the FY2025 annual figure was $346.6 million, down 2.25% from the prior year.
• Common Equity was $338.7 million for Q1 2026 at Orthopediatrics, down from $346.6 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $383.3 million in Q3 2022 to a low of $215.0 million in Q1 2022.
• Historically, Common Equity has averaged $347.9 million across 5 years, with a median of $370.6 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Common Equity jumped 73.52% in 2023, then fell 6.32% in 2025.
• A 5-year view of Common Equity shows it stood at $378.6 million in 2022, then dropped by 0.43% to $377.0 million in 2023, then dropped by 5.96% to $354.6 million in 2024, then decreased by 2.25% to $346.6 million in 2025, then declined by 2.27% to $338.7 million in 2026.
• The last three Common Equity figures came in at $338.7 million (Q1 2026), $346.6 million (Q4 2025), and $349.3 million (Q3 2025), per Business Quant data.